HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Infantino Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

1/2022Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus.
12/2015Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases.
1/2015Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Infantino Research Topics

Disease

19Rheumatoid Arthritis
01/2022 - 01/2013
12Rheumatic Diseases (Rheumatism)
01/2022 - 01/2013
8COVID-19
12/2021 - 01/2020
7Arthritis (Polyarthritis)
01/2022 - 01/2017
6Autoimmune Diseases (Autoimmune Disease)
01/2022 - 12/2015
5Myositis (Idiopathic Inflammatory Myopathies)
10/2022 - 01/2018
5Psoriatic Arthritis
01/2022 - 04/2016
5Infections
11/2021 - 04/2016
5Ankylosing Spondylitis
01/2020 - 01/2017
3Connective Tissue Diseases (Connective Tissue Disease)
01/2022 - 03/2017
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 01/2015
3Muscular Diseases (Myopathy)
01/2021 - 10/2016
3Necrosis
01/2021 - 01/2013
2Neoplasms (Cancer)
10/2022 - 03/2020
2Celiac Disease (Celiac Sprue)
10/2021 - 01/2021
2Disease Progression
01/2021 - 01/2015
2Pain (Aches)
01/2021 - 01/2017
2Hypersensitivity (Allergy)
01/2015 - 01/2013
1Skin Manifestations
10/2022
1Dermatomyositis (Dermatopolymyositis)
10/2022
1Inclusion Body Myositis
10/2022
1Calcinosis
10/2022
1Vasculitis (Vasculitides)
01/2022
1Membranous Glomerulonephritis (Membranous Nephropathy)
04/2021
1Mood Disorders (Mood Disorder)
01/2021
1Inflammation (Inflammations)
01/2021
1Lung Diseases (Lung Disease)
01/2021
1Fatigue
01/2021
1Synovitis
01/2021
1Pneumonia (Pneumonitis)
11/2020
1Autoimmune limbic encephalitis
01/2020
1Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
01/2020
1Thrombosis (Thrombus)
01/2020
1Undifferentiated Connective Tissue Diseases
07/2018
1Heart Diseases (Heart Disease)
01/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2018
1Ulcerative Colitis
01/2017
1Crohn Disease (Crohn's Disease)
01/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017
1Myocardial Infarction
10/2016
1Stroke (Strokes)
10/2016

Drug/Important Bio-Agent (IBA)

25AntibodiesIBA
10/2022 - 01/2013
10AutoantibodiesIBA
10/2022 - 10/2016
7Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2016
5Biological ProductsIBA
07/2020 - 01/2013
5tocilizumab (atlizumab)FDA Link
01/2020 - 01/2014
4Immunoglobulins (Immunoglobulin)IBA
11/2021 - 01/2015
4Immunoglobulin A (IgA)IBA
10/2021 - 01/2013
4Immunoglobulin M (IgM)IBA
01/2021 - 01/2013
4Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2021 - 01/2017
3Proteins (Proteins, Gene)FDA Link
10/2022 - 03/2020
3VaccinesIBA
01/2022 - 01/2021
3Rheumatoid FactorIBA
01/2021 - 09/2014
3Anti-Citrullinated Protein AntibodiesIBA
01/2021 - 09/2014
3Immunoglobulin G (IgG)IBA
09/2020 - 01/2015
3Antirheumatic Agents (DMARD)IBA
07/2020 - 01/2016
3Abatacept (Orencia)FDA Link
01/2019 - 04/2016
3Pharmaceutical PreparationsIBA
02/2018 - 01/2016
3Infliximab (Remicade)FDA Link
01/2018 - 01/2013
2Ligases (Synthetase)IBA
10/2022 - 01/2018
2anti-dsDNA autoantibodyIBA
01/2022 - 01/2018
2Messenger RNA (mRNA)IBA
01/2022 - 01/2021
2BNT162 VaccineIBA
01/2022 - 12/2021
2Neutralizing AntibodiesIBA
01/2022 - 12/2021
2Rituximab (Mabthera)FDA Link
01/2021 - 08/2020
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 10/2020
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2020 - 10/2016
2Antinuclear AntibodiesIBA
10/2019 - 01/2019
2Adalimumab (Humira)FDA Link
01/2018 - 01/2013
2Etanercept (Enbrel)FDA Link
01/2018 - 01/2013
2Cartilage Oligomeric Matrix ProteinIBA
02/2015 - 01/2014
1RNA (Ribonucleic Acid)IBA
10/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
01/2022
1COVID-19 VaccinesIBA
12/2021
1Phospholipase A2 ReceptorsIBA
04/2021
1Dichlororibofuranosylbenzimidazole (DRB)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1TransglutaminasesIBA
01/2021
1SuspensionsIBA
01/2021
1SteroidsIBA
01/2021
1Protein Glutamine gamma Glutamyltransferase 2IBA
01/2021
1sarilumabIBA
11/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020
1Synthetic DrugsIBA
03/2020
1ixekizumabIBA
01/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2018
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1Prednisone (Sone)FDA LinkGeneric
01/2018
1golimumabFDA Link
01/2018
1ElementsIBA
03/2017
1ImmunosorbentsIBA
01/2017
1EnzymesIBA
01/2017
1Biosimilar PharmaceuticalsIBA
01/2017
1Coenzyme A (CoA)IBA
10/2016
1Oxidoreductases (Dehydrogenase)IBA
10/2016

Therapy/Procedure

8Therapeutics
01/2022 - 01/2015
2Biological Therapy
04/2020 - 04/2016
1Activities of Daily Living (ADL)
01/2021
1Self Administration (Administration, Self)
01/2021